Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase I clinical trial updates indicate completion of a safety, tolerability, and pharmacokinetics evaluation of YHB1411-2 in healthy male volunteers for rheuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• YHB1411-2 (YHB1411-2)

Snippet

Sponsor: Yuhan Corporation | Conditions: Rheumatic Arthritis | Phase 1 | Status: COMPLETED